DR. JOEL S KARLINER, MD
Osteopathic Medicine at Clement St, San Francisco, CA

License number
California G10623
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
4150 Clement St, San Francisco, CA 94121
Phone
(415) 221-4810

Personal information

See more information about JOEL S KARLINER at radaris.com
Name
Address
Phone
Joel Karliner, age 88
4089 26Th St, San Francisco, CA 94131
Joel S Karliner
125 Gilbert St, San Francisco, CA 94103
Joel S Karliner, age 88
4089 26Th St, San Francisco, CA 94131
Joel S Karliner
439 35Th Ave, San Francisco, CA 94121
(415) 751-9411
Joel S Karliner
439 35Th Ave, San Francisco, CA 94121
(415) 751-9411

Organization information

See more information about JOEL S KARLINER at bizstanding.com

Joel S Karliner

4150 Clement St, San Francisco, CA 94121

Industry:
Grant Reviewer
Medical Doctor, Owner:
Joe S. Karliner (Medical Doctor, Owner)

Professional information

Joel Samuel Karliner Photo 1

Joel Samuel Karliner, San Francisco CA

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
San Francisco Veterans Affairs Medical Center
4150 Clement St, San Francisco, CA 94121
Education:
Columbia University (1962)


Joel Karliner Photo 2

Pyrroloquinoline Quinone Drugs And Methods Of Use Thereof

US Patent:
2008005, Feb 28, 2008
Filed:
May 2, 2007
Appl. No.:
11/799958
Inventors:
Paul Davis - West Sand Lake NY, US
Joel Karliner - San Francisco CA, US
Shaker Mousa - Wynantskill NY, US
George Drusano - Albany NY, US
International Classification:
A61K 31/437
US Classification:
514292000
Abstract:
The invention includes compositions comprising substantially purified pyrroloquinoline quinone, that are useful in methods for the treatment and prevention of cardiac injury caused by hypoxia or ischemia. The invention also includes methods for the treatment and prevention of cardiac injury comprising contacting a composition of the invention with a human patient.


Joel Karliner Photo 3

Pharmaceutical Compositions Containing Pyrroloquinoline Quinone And Nephroprotectant For Treating Ischemia Reperfusion Injuries

US Patent:
2010016, Jun 24, 2010
Filed:
Dec 22, 2009
Appl. No.:
12/644262
Inventors:
Paul J. Davis - West Sand Lake NY, US
Joel S. Karliner - San Francisco CA, US
Shaker A. Mousa - Wynantskill NY, US
George L. Drusano - Latham NY, US
Assignee:
CLF Medical Technology Acceleration Program, Inc. - Clifton Park NY
International Classification:
A61K 31/4745, A61P 9/10, A61P 13/12
US Classification:
514292
Abstract:
The invention includes compositions comprising substantially purified pyrroloquinoline quinone, that are useful in methods for the treatment and prevention of cardiac injury caused by hypoxia or ischemia. The invention also includes methods for the treatment and prevention of cardiac injury comprising contacting a composition of the invention with a human patient.


Joel Karliner Photo 4

Use Of Interleukin-15 To Treat Cardiovascular Diseases

US Patent:
2013025, Oct 3, 2013
Filed:
Jul 8, 2011
Appl. No.:
13/809154
Inventors:
Yerem Yeghiazarians - San Francisco CA, US
Joel S. Karliner - San Francisco CA, US
Andrew Boyle - San Francisco CA, US
Franca Angeli - San Francisco CA, US
Jean-Philippe Coppe - San Francisco CA, US
International Classification:
A61K 38/20
US Classification:
424 852, 435375
Abstract:
The present disclosure relates generally to the field of cardiovascular diseases. In particular, the present disclosure relates to methods and compositions for treating cardiovascular diseases by administration of a cytokine alone, or in conjunction with other therapeutic agents.


Joel Karliner Photo 5

Pyrroloquinoline Quinone Drugs For Treatment Of Cardiac Injury And Methods Of Use Thereof

US Patent:
2005026, Dec 1, 2005
Filed:
May 5, 2005
Appl. No.:
11/122572
Inventors:
Paul Davis - West Sand Lake NY, US
Joel Karliner - San Francisco CA, US
International Classification:
A61K031/4745
US Classification:
514291000
Abstract:
The invention includes compositions comprising substantially purified pyrroloquinoline quinone, that are useful in methods for the treatment and prevention of cardiac injury caused by hypoxia or ischemia. The invention also includes methods for the treatment and prevention of cardiac injury comprising contacting a composition of the invention with a human patient.